Trial Profile
Incidence of cardiotoxicity during long-term treatment with trastuzumab HER-2 positive patients, with advanced breast cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 09 Dec 2015 New trial record